Introduction

Acute kidney injury (AKI) is a major complication reported in patients after an operation. In patients undergoing major surgery, the incidence of AKI is reported to be around 6.1–22.4%. AKI is associated with extended duration of hospital stay, cost, and mortality [1,2,3]. Development of AKI could contribute to the development of chronic kidney disease (CKD) or end-stage renal disease (ESRD). There is a gradual increase in the incidence of AKI and its impact on long-term health and cost is far greater than previously acknowledged [4]. Therefore, an early and rapid diagnosis and treatment of AKI are crucial in the management of patients with syndromes caused or associated with AKI [4, 5]. Since there are no widely used prediction models for AKI in noncardiac surgery, there is a growing need for the discovery of novel correlation biomarkers of AKI.

Among the existing methods, preoperative determination of certain biomarkers has been increasingly used in the prediction of postoperative adverse outcomes [6, 7]. The neutrophil-to-lymphocyte ratio (NLR) is a commonly used prognostic marker that is indicative of systemic inflammation and resulting immunosuppression. Recent studies have reported an association between that high levels of NLR with severe COVID-19 and mortality [8]. NLR has also been associated with adverse outcomes in malignant tumors including breast, ovary, and lung [9, 10]. AKI could independently contribute to an increase in mortality via impairment of neutrophil function and the patient’s inability to effectively clear the infection [11]. In some cases, elevated levels of neutrophil gelatinase-associated lipocalin (NGAL) could be indicative of renal impairment in the absence of any other indicators of AKI [11,12,13]. However, there is not enough evidence to suggest the association of preoperative NLR with an increased prevalence of postoperative AKI and in-hospital mortality after noncardiac surgery. In this study, we investigated the relationship of NLR associated with major noncardiac surgery with postoperative AKI and postoperative in-hospital mortality.

Materials and methods

Study design and data collection

This study was approved by Ethical Committee on Biomedical Research (Ethical Committee 554), West China Hospital of Sichuan University (Chairperson Prof Deng Shaolin) on May 13, 2021. This is a retrospective observational study, which meets the requirement of “Strengthening observational studies in epidemiological statements”. Original data were retrieved from the Hospital Information System and the Anesthesia Information Management System. Owing to the sensitivity of the data, data collection was performed blindly by the staff of the hospital data processing center. Baseline characteristics of the preoperative assessment forms were compiled into standardized forms by independent investigators. Subsequent data analysis was performed by qualified researchers abiding by the confidentiality agreement for human subjects. All data were anonymously identified and analyzed for confidentiality purposes.

A total of 165,803 patients aged no less than 18 years who underwent elective or emergency surgery at the Information Center of West China Hospital of Sichuan University from February 2018 to November 2020 were included in this study using database analysis. Patients were excluded for the following reasons: (1) they were undergoing cardiac, ophthalmic, obstetric, urologic, or diagnostic surgery; (2) preoperative NLR measurements were not available; (3) serum creatinine levels were not measured before or during one week after surgery; (4) presence of coexisting end-stage renal disease.

The primary outcome of the data analyses was postoperative AKI and in-hospital mortality. AKI was defined by the serum creatinine criteria of the kidney disease: Improving Global Outcomes (KDIGO) criteria classification [14]. Based on the serum creatinine criteria, AKI was indicated by an increase in serum creatinine of ≥ 26.5 mmol/L within 48 h after surgery or ≥ 1.5 times baseline within seven postoperative days. Preoperative concentration was defined as the most recent recorded measurement taken within 14 days before the surgery. NLR was calculated based on recorded absolute total neutrophil and lymphocyte counts (dividing the number of the former by the number of the latter), based on the last preoperative routine blood test. The elevated NLR group was defined as corresponding to NLR ≥ 5 serum levels and the other patients were categorized into the normal group.

Statistical analysis

The demographics of patients and variables of perioperative tests between the preoperative NLR groups (normal versus elevated NLR) were defined. Continuous data were analyzed using the Student’s t test or the Mann–Whitney test for differences between the compared groups. The results were represented in terms of the median and interquartile range (25th–75th percentile) or mean ± SD. Categorical data were compared using the Fisher exact test or X2 test and presented as numbers (percentages). A P value of < 0.05 was considered statistically significant.

We used multivariable logistic regression models to the association of preoperative serum NLR with postoperative AKI while adjusting for potential confounding variables (model 1). LASSO (Least Absolute Shrinkage and Selection Operator) approach was applied to further select variables in a logistic regression model. The data were adjusted for the following variables to understand the effect of NLR on postoperative AKI and in-hospital mortality: sex; age; anesthesia duration; the American Society of Anesthesiologists Physical Status (ASA PS); emergency surgery; general anesthesia; comorbid diseases: hypertension, transplanted organ, liver disease; WBC; Hemoglobin (HB); albumin; γ-glutamyl transpeptidase; serum kalium (K); serum magnesium (Mg); surgical subspecialty: central nervous system, general, other; urine output (ml/kg/h); duration of mean arterial pressure (MAP) < 50 mmHg. As part of the sensitivity analysis, NLR was included as a continuous variable for postoperative AKI in multivariable regression analysis (model 2), instead of a dichotomous variable which was bounded by a cutoff point of 5. We used a restricted cubic spline to model potential nonlinear relationships between the risk of outcomes and NLR. The results were represented in terms of odds ratios (ORs) with 95% CIs. A P value of < 0.05 was considered statistically significant.

The association between preoperative NLR and postoperative AKI was further investigated using propensity-score (PS) matching to balance measured baseline confounders and risk factors. A logistic regression model was constructed based on roughly the same variables of multivariable logistic regression analysis for calculating the PS for each subject of the two groups, which were categorized based on the preoperative NLR values. PS matching between the two groups (≥ 5 of the NLR group vs. the < 5 of NLR groups) was performed in a one-to-one fashion by calipers of width equal to 0.1 of the standard deviation of the logit of the PS. Covariate balances after matching were validated by comparing the standardized differences [15]. After PS matching, a standardized difference greater than 10% was considered imbalanced. Pearson χ2 test was performed to compare the prevalence of postoperative AKI between the two groups.

Multivariable logistic regression analysis was further performed to develop the following risk model: risk score = (0.75 × sex) + (1.01 × age) + (1.91 × Anesthesia duration) + (1.64 × ASA PS grades) + (0.67 × emergency surgery) + (0.41 × General anesthesia) + (2.0 × Hypertension) + (3.51 × Transplanted organ) + (1.22 × Liverdisease) + (0.99 × HB) + (0.99 × Albumin) + (1.32 × Albumin) + (0.16 × Mg) + (1.43 × Department) + (0.84 × Urine output) + (1.83 × Duration of MAP < 50 mmHg) + (1.23 × NLR). Receiver operating characteristic plots were used to compute the sensitivity and specificity.

R version 4.1.3 software was used to carry out statistical analyses. In this study, P < 0.05 was considered statistically significant and all tests carried out were 2-tailed.

Results

Baseline characteristics

A total of 144,137 patients were excluded from a total of 188,202 patients undergoing elective or emergency surgery during the study period for various reasons (Fig. 1). A total of 44, 065 patients were finally included in the study. Baseline patient characteristics, preoperative and perioperative variables were compared between patients with normal NLR and elevated NLR groups and are summarized in Table 1. A total of 6588 patients (14.95%) demonstrated elevated preoperative NLR, while 37,477 (85.05%) exhibited normal levels. In the current study, postoperative AKI was prevalent in 2477 patients (5.62%), including 1826 patients (4.14%) with KDIGO Stage 1, 349 patients (0.79%) with Stage 2, and 302 patients (0.69%) with Stage 3 AKI. A total of 704 patients died following the operation corresponding to a mortality rate of 1.58%.

Fig. 1
figure 1

Patient flowchart

Table 1 Baseline patient characteristics in relation to preoperative NLR

According to the baseline patient characteristics (Table 1), the proportion of male patients was significantly higher (P < 0.001) in the ≥ 5 NLR group than that in the < 5 NLR group. BMI was found to be significantly lower (P < 0.001) in patients with ≥ 5 of NLR. Furthermore, patients with elevated NLR had higher ASA PS grades, and a higher prevalence of emergency surgery, central nervous system surgery, hypertension, diabetes, and cerebrovascular disease (P < 0.05). The duration of mean arterial pressure < 50 mmHg was significantly longer in the NLR ≥ 5 group (P < 0.001). Additionally, there was significantly more colloid and crystalloid infusion in the NLR ≥ 5 group (P < 0.001), but the urine output was significantly lower in the NLR ≥ 5 group (P < 0.001) than in the NLR < 5 group. Moreover, the NLR ≥ 5 group had longer hospital days and a higher proportion of unplanned ICU admissions than the NLR < 5 groups (P < 0.001).

NLR and postoperative outcomes

The crude AKI rate was found to be 4.94% (1853 patients) for patients with normal NLR compared to that of 9.47% (624 patients) in patients with elevated NLR (OR 2.61, 2.32- 2.94; P < 0.001). Similarly, crude mortality was found to be 0.7% (251 patients) in patients with normal NLR, which was significantly lower than that in the elevated NLR group (6.9%, 453 patients; OR 10.95, 9.37–12.82; P < 0.001). A total of 21 variables were included in the model for multivariable logistic regression analysis (Table 2). NLR ≥ 5 was independently associated with the development of postoperative AKI (OR 1.42, 1.24- 1.73; P < 0.001) and mortality (OR 2.03, 1.63- 2.52; P < 0.001) after adjusting for potential confounding factors (sex; age; anesthesia duration; ASA PS; emergency surgery; general anesthesia; comorbid diseases: hypertension, transplanted organ, liver disease; γ-glutamyl transpeptidase; surgical subspecialty; urine output (ml/kg/h); duration of MAP < 50 mmHg; Hemoglobin (HB); albumin) (Table 2, model 1).

Table 2 Multivariable logistic regression model for association between preoperative NLR and postoperative acute kidney injury

Patient characteristics and intraoperative variables after PS matching on NLR are summarized in Table 3. All variables achieved standardized differences not greater than 10%, which implied efficient balancing of the two groups. The prevalence of postoperative AKI was significantly higher in patients with ≥ 5 of NLR (8.81%, 380 patients; OR = 1.71, 95% CI, 1.57–2.29; P < 0.001) as compared to patients with < 5 of NLR (4.92%, 212 patients), following PS matching. Similarly, postoperative in-hospital mortality was significantly greater in patients with ≥ 5 of NLR (206 patients, 4.8%) than that in patients with < 5 of NLR (2.6%, 114 patients; OR = 1.80, 1.39–2.33; P < 0.001). These findings were consistent with the results obtained before propensity-score matching.

Table 3 Propensity-score matching of patient characteristics and intraoperative variables

Subgroup analysis

Subgroup analyses were performed based on ASA physical status, surgical urgency, type of anesthesia, surgical site, as well as hypertension, diabetes, intraoperative urine output, and preoperative GFR, which are factors previously reported to be associated with AKI. After adjustment for all potential confounders listed in Table 2 by multivariable logistic regression, elevated levels of preoperative NLR remained independent and significantly associated with increased incidences of postoperative AKI and mortality in most subgroups. With stratification by IV-V ASA PS, cerebrovascular disease, ischemic heart disease and diabetes existed subgroups, the risk of AKI was higher in the NLR ≥ 5 group than that in the normal NLR group, however, the difference failed to achieve statistical significance (Table 4).

Table 4 OR (95% CI) for the association between elevated NLR and postoperative AKI and death in subgroups

Construction of a risk model based on NLR for predicting the risk of postoperative outcomes

The serum NLR concentration, which was originally a skewed distribution, conformed to normal distribution after logarithmic transformation (Fig. 2). After applying the base-2 logarithm, the multivariable regression analysis produced similar results. As demonstrated by outcomes of Model 2 summarized in Table 2, preoperative serum NLR levels were associated with postoperative AKI (OR 1.30, 1.18–1.44; P < 0.001) and in-hospital mortality (OR 1.58, 1.39–1.78; P < 0.001). As shown in Fig. 3, the probability of postoperative AKI increased almost linearly in the logarithmic NLR level. There was a corresponding increase in mortality as well.

Fig. 2
figure 2

NLR distribution (a) and logarithmic transformed NLR distribution (b)

Fig. 3
figure 3

The restricted cubic spline of postoperative AKI (a) and Death (b) after noncardiac surgery, according to preoperative NLR levels. AKI, acute kidney injury; NLR, neutrophil-to-lymphocyte ratio.

Finally, a risk model was constructed based on the outcomes of multivariable regression, which contained NLR. As illustrated in Fig. 4, the area under the receiver operating characteristic (AUROC) of the risk score in predicting postoperative AKI was 0.778, the specificity was estimated to be 0.758, with a corresponding sensitivity of 0.654. The AUROC of the risk score in predicting postoperative mortality was 0.849, with a specificity of 0.777, and a sensitivity of 0.778.

Fig. 4
figure 4

Receiver operating characteristic curves for risk score associated with postoperative AKI (a), and Death (b) after noncardiac surgery. AKI, acute kidney injury

Discussion

A retrospective database analysis was performed on a total of 44,065 surgical cases to understand the relationship between preoperative NLR and postoperative AKI and in-hospital mortality in cases of major surgeries apart from cardiac surgeries. The incident rate of AKI was found to be 5.62% in noncardiac surgical cases estimated based on the serum creatinine criteria of the KDIGO classification. NLR values were categorized into normal and elevated groups based on a cutoff value of 5. Outcomes of multivariable regression analysis and PS matching indicated that NLR ≥ 5 was significantly associated with the development of postoperative AKI and in-hospital mortality.

Furthermore, the findings of this study demonstrated that elevated NLR levels could contribute to a steadily increased risk of adverse events in most subgroup analyses. In the ASA PS IV-V subgroup, elevated NLR was not significantly associated with increased prevalence of postoperative AKI (OR 1.11, 0.98–1.63; P = 0.213). This could be due to the presence of existing elevated NLR levels in critically ill patients before the surgery. In addition, we constructed a risk model based on the outcomes of multivariable regression analysis, which included NLR, moreover, the risk score established by predictive factors exhibited excellent accuracy (AUC of AKI = 0.778; AUC of death = 0.849).

The findings of our study suggest that preoperative NLR can be independently associated with the development of postoperative AKI and in-hospital mortality after noncardiac surgery.

The prevalence of AKI in our study was found to be slightly lower than previously reported. This could be attributed to the exclusion of patients with cardiac surgery, urology surgery, and preoperatively existing end-stage renal disease, comprising the high-risk groups for postoperative kidney injury. The majority of excluded patients had no creatinine measurement.

AKI is the most common urologic complication among the perioperative complications of noncardiac surgeries and is independently associated with postoperative mortality. Our findings suggest that NLR could be a contributing risk factor responsible for the increased rate of AKI in noncardiac surgeries. Moreover, the occurrence of AKI may have a certain correlation between preoperative NLR and postoperative mortality. The routine diagnosis of AKI includes an estimation of clinical manifestations such as urine output and creatinine. However, this approach is time-consuming [16], causing a significant delay in the diagnosis and treatment. Nearly 50% of GFR must be lost in a healthy person before a change in serum creatinine is clinically detectable [17, 18]. Unlike routine biomarkers that have been reported to predict kidney injury such as urine interleukin-18 and plasma neutrophil gelatinase-associated lipocalin [5, 11], estimation of NLR is more convenient and cheaper. Moreover, all hospitalized patients are routinely tested for NLR status. Our findings may assist medical staff to stratify patients based on risk, which may further assist in the implementation of prophylactic strategies and optimization of effective use of existing resources. Clinical outcomes of the patients could be significantly improved using this approach.

Our study identified other factors that exhibited independent correlation with the progression of postoperative AKI and in-hospital mortality, including sex, age, surgery type (neurosurgery, gastrointestinal surgery, other surgery), emergency surgery, ASA PS, γ-glutamyl transpeptidase, duration of MAP < 50 mmHg (0 min; 1–30 min; > 30 min) and urine output. Perioperative management (e.g., prevention of hypothermia; hemodynamic optimization; and avoiding nephrotoxins) may reduce postoperative adverse events in patients with these high-risk factors.

Strengths and limitations

As per our understanding, this is the first study to demonstrate the association of preoperative NLR with postoperative AKI. Our findings could be of great clinical significance for preoperative NLR management in postoperative patients. This study included patients who underwent noncardiac surgeries in the largest tertiary hospital in China’s western region. Selection bias was reduced to a minimum using stringent inclusion criteria. The results of the study were further validated by PS matching and multivariable regression analysis on NLR. NLR was considered as a continuous variable to establish the potential linear relationship between NLR and postoperative AKI and mortality. An additional subgroup analysis was also carried out.

However, there are a few limitations to this study. Firstly, this study was carried out in a single center, which may not be a good representation of the clinical conditions. Secondly, there was unavailability of a few crucial pieces of information (such as postoperative urine output and preoperative information regarding drug use). The unavailability of this information could impact further assessment of the characteristics and pathogenesis of postoperative AKI. Thirdly, although we used propensity-score matching methods and multivariable logistic regression to reduce the impact of confounding variables, confounding bias could still be introduced due to unadjusted factors, such as the bispectral index of electroencephalogram (EEG) and perioperative care.

Conclusion

To summarize, an elevated level of preoperative serum NLR is associated with an increased risk of postoperative AKI and in-hospital mortality in noncardiac surgeries. Our results suggest that NLR could be a potential biomarker that could be used in perioperative risk assessment of patients undergoing noncardiac surgeries.